Radnor, Pennsylvania, January 2, 2022 (Global News Agency)-American law firm Kessler Topaz Meltzer & Check, LLP Investors are notified that the U.S. District Court for the Northern District of California has imposed an action against Ginkgo Bioworks Holdings, Inc. (“Ginkgo”) (NYSE stock code:DNA) f/k/a Soaring Eagle Acquisition Corp. (NASDAQ:random number). The lawsuit accused Ginkgo of violating federal securities laws, including omissions and fraudulent misrepresentations related to the company’s business, operations, and prospects. Due to Ginkgo’s major misleading statements to the public, Ginkgo investors suffered heavy losses.
Can’t watch this video?Please click here
click here arrive submit Your ginkgo loss
Deadline for lead plaintiff: January 18, 2022
Class time: May 11, 2021 to October 5, 2021
Contact a lawyer to discuss your rights:
James Marlow, Esq. (484) 270-1453 or toll free (844) 887-9500 or email to [email protected]
ginkgo Suspected misconduct
Headquartered in Boston, Ginkgo is a biotechnology company that develops cell programming platforms for the biological production of products, such as new therapies, food ingredients, and chemicals currently extracted from petroleum.
October 6, 2021, analyst Scorpion Capital Published an investigation report and concluded that “Ginkgo is a house of cards…